Medical Director, Clinical Development – MRD Portfolio (Solid Tumors)

Role: Medical Director, Clinical Development for Labcorp Oncology's MRD portfolio, focusing on solid tumors. Objectives include shaping clinical strategies, generating evidence for product validation, utility, reimbursement, and clinical adoption of MRD and ctDNA technologies. Responsibilities encompass leading evidence-generation programs across multiple tumor types, collaborating with internal teams (research, medical affairs, market access, regulatory) and external stakeholders (investigators, societies, payers). The role supports portfolio lifecycle management, clinical utility demonstration, and scientific communication, advocating for MRD integration into cancer care. Qualifications: MD or DO, board-certified in Medical Oncology, with 5+ years of post-fellowship clinical experience in solid tumors, alongside 3+ years in clinical research, evidence generation, or product development in biotech, diagnostics, or pharma. Preferred: 5+ years in molecular diagnostics, biomarker-driven oncology, and experience leading translational research, evidence programs, and regulatory submissions; minimum 20 peer-reviewed publications. High-value specifics: focus on liquid biopsy, minimal residual disease, precision oncology, multiple solid tumor indications, and involvement in regulatory and reimbursement strategies. The role involves cross-functional leadership, external scientific engagement, and travel up to 30%. Work setup: standard Monday–Friday schedule.